Efficacy of Sucralfate in Refractory Reflux Esophagitis:Results of a Pilot Study

References

• Dodds W J, Hogan W J, Helm J F, Dent J. Pathogenesis of reflux esophagitis. Gastroenterology 1981; 81: 376–394
   PubMed Web of Science ®Google Scholar
• Richter J E, Castell D O. Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy. Ann Intern Med 1982; 97: 93–103
   PubMed Web of Science ®Google Scholar
• Richter J E. Acid perfusion (Bernstein) test. Gastroesophageal Reflux Disease: Pathogenesis, Diagnosis, and Therapy, D O Castell, W C Wu, D J Ott. Mount Kisco, New York, Futura 1985; 221–241
   Google Scholar
• Richardson C T. Sucralfate (editorial). Ann Intern Med 1982; 97: 269–272
   PubMed Web of Science ®Google Scholar
• Brogden R N, Heel R C, Speight T M, Avery G S. Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease. Drugs 1984; 27: 194–209
   PubMed Web of Science ®Google Scholar
• Paull A, Trier J S, Dalton M D, Camp R C, Loeb P, Goyal H K. The histologic spectrum of Barrett's esophagus. N Engl J Med 1976; 295: 476–480
   PubMed Web of Science ®Google Scholar
• Dodds W J. Instrumentation and methods for intraluminal esophageal manometry. Arch Intern Med 1976; 136: 515–523
   PubMed Web of Science ®Google Scholar
• Welch R W, Drake S T. Normal lower esophageal sphincter pressure: a comparison of rapid vs. slow pull-through techniques. Gastroenterology 1980; 78: 1446–1451
   PubMed Web of Science ®Google Scholar
• Behar J, Biancani P, Sheahan D G. Evaluation of esophageal tests in the diagnosis of reflux esophagitis. Gastroenterology 1976; 71: 9–15
   PubMed Web of Science ®Google Scholar
• Sillin L F, Condon R E, Wilson S D, Worman L W. Effective surgical therapy of esophagitis. Experience with Belsey, Hill, and Nissen operations. Arch Surg 1979; 114: 536–541
   PubMedGoogle Scholar
• Brand D L, Eastwood I R, Martin D, Carter W B, Pope C E. Esophageal symptoms, manometry, and histology before and after antireflux surgery: a long-term follow-up study. Gastroenterology 1979; 76: 1393–1401
   PubMed Web of Science ®Google Scholar
• Zucker K, Peskin G W, Saik R P. Recurrent hiatal hernia repair: A potential surgical dilemma. Arch Surg 1982; 117: 413–414
   PubMedGoogle Scholar
• Washer G F, Gear M W, Dowling B L, Gillison E W, Royston C M, Spencer J. Randomized prospective trial of Roux-en-Y duodenal diversion versus fund-oplication for severe reflux oesophagitis. Br J Surg 1984; 71: 181–184
   PubMed Web of Science ®Google Scholar
• Bron B, Massih L. Domperidone: a drug with powerful action on the lower esophageal sphincter pressure. Digestion 1980; 20: 375–378
   PubMed Web of Science ®Google Scholar
• Weihrauch T R, Foerster C F, Krieglstein J. Evaluation of the effect of domperidone on human oesophageal and gastroduodenal motility by intraluminal manometry. Postgr Med J 1979; 55(Suppl 1)7–10
   PubMedGoogle Scholar
• Castell D O. Medical therapy for reflux esophagitis: 1986 and beyond. Ann Intern Med 1986; 104: 112–114
   PubMed Web of Science ®Google Scholar
• Ferguson R, Dronfield M W, Atkinson M. Cimetidine in treatment of reflux oesophagitis with peptic stricture. Br Med J 1979; 2: 472–474
   PubMed Web of Science ®Google Scholar
• Spechler S J, Goval R K. Barrett's esophagus. N Engl J Med 1986; 315: 362–371
   PubMed Web of Science ®Google Scholar
• Samloff M., O'Dell C. Inhibition of peptic activity bv sucralfate. Am. J Med 1985; 79(suppl 2C)15–18
   PubMedGoogle Scholar
• Bruusgaard A, Elsbord L, Reinecke V. Bile acid binding properties of sucralfate. Duodenal Ulcer, Gastric Ulcer: Sucralfate. A New Therapeutic Concept, W F Caspary. Urban & Schwarzen-berg, Munich 1981; 28–31
   Google Scholar
• Hollander D, Tarnawski A, Gergely H, Zipser R D. Sucralfate protection of the gastric mucosa against ethanol-induced injury: a prostaglandin-mediated process?. Scand J Gastroenterol 1984; 19(suppl 101)97–102
   PubMedGoogle Scholar
• Tarnawski A. Prevention and treatment of gastrointestinal mucosal injury with cytoprotective agents. Med J Austral 1985; 142: 13–17
   Google Scholar
• Ligumsky M, Karmeli F, Rachmilewitz D. Sucralfate protection against gastrointestinal damage: possible role of prostanoids. Israel J Med Sci 1986; 22: 801–806
   PubMedGoogle Scholar
• Konturek S J, Kwiecien N, Obtulowicz W, Kopp B, Olesky J. Double blind controlled study on the effect of sucralfate on gastric prostaglandin formation and microbleeding in normal and aspirin treated man. Gut 1986; 27: 1450–1456
   PubMed Web of Science ®Google Scholar
• Orlando R C, Turjman N A, Tobey N A, Schreiner V J, Powell D W. Mucosal protection by sucralfate and its components in acid-exposed rabbit esophagus. Gastroenterology 1987; 93: 352–361
   PubMed Web of Science ®Google Scholar
• Schweitzer E J, Bass B L, Johnson L F, Harmon J W. Sucralfate prevents experimental peptic esophagitis in rabbits. Gastroenterology 1985; 88: 611–619
   PubMed Web of Science ®Google Scholar
• Tobey N A, Orlando R C, Schreiner V J, Powell D W. Cytoprotective effect of sulfate ions in acid-exposed rabbit esophagus. Am J Phvsiol 1986; 251: 866–869
   Google Scholar
• Pleet D, Malmud L S, Maurer A, Krevsky B, Knight L, D'Ercole F, Fisher R S, et al. Sucralfate binding to inflamed esophageal mucosa (Abstract). Gastroenterology 1985; 88: 1540
   Google Scholar
• Van Deventer J M, Coyle J J, Schneidman D S, Weinstein M W, Blahd W H. Sucralfate binding in esophagitis (Abstract). Gastroenterology 1986; 90: 1675
   Web of Science ®Google Scholar
• Berges W, Sonnenberg A, Wienbeck M. Sucralfate in reflux esophagitis. Dtsch Med Wschr 1981; 106: 853–854
   Web of Science ®Google Scholar
• Elsborg L, Beck B, Stubgaard M. Effect of sucralfate on gastroesophageal reflux in esophagitis. Hepato-Gastroenterol 1985; 32: 181–184
   PubMedGoogle Scholar
• Weiss W, Brunner H, Buettner G R, Gabor M, Mie-Derer S, Mittelstaedt A, Olbermann M, et al. Therapie der Refluxoesophagitis mit Sucralfat. Dtsch Med Wschr 1983; 108: 1706–1711
   PubMed Web of Science ®Google Scholar
• Laitinen S, Stahlberg M, Kairaluoma M I, Kiviniemi H, Paeaekkoenen M, Lahtinen J, Poikolainen E, Aukee S. Sucralfate and alginate/antaeid in reflux esophagitis. Scand J Gastroenterol 1985; 20: 229–232
   PubMed Web of Science ®Google Scholar
• Evreux M. Sucralfate versus alginate/antaeid in the treatment of peptic esophagitis. Am J Med 1987; 83(suppl 3B)48–50
   PubMed Web of Science ®Google Scholar
• Simon B, Mueller P. Comparison of die effect of sucralfate and ranitidine in reflux esophagitis. Am J Med 1987; 83(suppl 3B)43–47
   PubMed Web of Science ®Google Scholar
• vd. Hameeteman W, Boomgard D M, Dekker W, Schrijver M, Wesdorp I CE, Tytgat G NJ. Sucralfate versus cimetidine in reflux esophagitis. A single-blind multicenter studv. J Clin Gastroenterol 1987; 9: 390–394
   PubMedGoogle Scholar
• Reed P I, Davies W A. Controlled trial of a new dosage form of carbenoxolone (Pyrogastrone) in the treatment of reflux esophagitis. Am J Dig Dis 1978; 23: 161–165
   PubMedGoogle Scholar
• Markham C, Reed P I. Pyrogastrone treatment of peptic oesophagitis: analysis of 104 patients treated during a 3V2-vear period. Scand J Gastroenterol 1980; 15(suppl 65)73–79
   PubMedGoogle Scholar
• Goff J S, Adcock K A, Schmelter R. Detection of esophageal ulcerations with technetium-99m albumin sucralfate. JNucl Med 1986; 27: 1143–1146
   PubMed Web of Science ®Google Scholar